{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T20:41:48Z","timestamp":1778532108390,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ijantimicag.2019.11.010","type":"journal-article","created":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T11:16:11Z","timestamp":1574507771000},"page":"105853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Emergence of Haitian variant genotype and altered drug susceptibility in Vibrio cholerae O1 El Tor-associated cholera outbreaks in Solapur, India"],"prefix":"10.1016","volume":"55","author":[{"given":"Pramod","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priti","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kishor V.","family":"Ingole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi K.","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasira S.","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Durgesh G.","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay K.","family":"Goel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramod K.","family":"Yadava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0001","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1126\/science.aad5901","article-title":"Genomic history of the seventh pandemic of cholera in Africa","volume":"358","author":"Weill","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0002","series-title":"National treatment guidelines for antimicrobial use in infectious diseases. Version 1.0 (2016)","article-title":"Government of India","year":"2016"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0003","doi-asserted-by":"crossref","first-page":"O292","DOI":"10.1111\/1469-0691.12393","article-title":"Haitian variant ctxB producing Vibrio cholerae O1 with reduced susceptibility to ciprofloxacin is persistent in Yavatmal, Maharashtra, India, after causing a cholera outbreak","volume":"20","author":"Kumar","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0004","article-title":"Cholera in Yemen: why are vaccines not being used?","author":"van Seidlein","year":"2017","journal-title":"PLoS Blogs"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0005","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1099\/jmm.0.002089-0","article-title":"A large cholera outbreak due to a new cholera toxin variant of Vibrio cholerae O1 El Tor biotype in Orissa, Eastern India","volume":"58","author":"Kumar","year":"2009","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0006","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jinf.2008.06.015","article-title":"A new variant of Vibrio cholerae O1 El Tor causing cholera in India","volume":"57","author":"Goel","year":"2008","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0007","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1128\/JCM.00387-12","article-title":"Development and evaluation of a PCR assay for tracking the emergence and dissemination of Haitian variant ctxB in Vibrio cholerae O1 strains isolated from Kolkata, India","volume":"50","author":"Naha","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0008","article-title":"Emergence of tetracycline resistant Vibrio cholerae O1 biotype El Tor serotype Ogawa with classical ctxB gene from a cholera outbreak in Odisha, Eastern India","volume":"2016","author":"Jain","year":"2016","journal-title":"J Pathog"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0009","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.meegid.2014.03.020","article-title":"Vibrio cholerae O1 Ogawa El Tor strains with the ctxB7 allele driving cholera outbreaks in south-western India in 2012","volume":"25","author":"Kumar","year":"2014","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0010","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1128\/JCM.03042-13","article-title":"Haitian variant tcpA in Vibrio cholerae O1 El Tor strains in Kolkata, India","volume":"52","author":"Ghosh","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0011","series-title":"Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. CLSI document M100-S20","year":"2010"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0012","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.cmi.2017.06.019","article-title":"Vibrio cholerae O1 with ctxB7 variant genotype acquired qnrVC mediated ciprofloxacin resistance in Yavatmal, India","volume":"23","author":"Kumar","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0013","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1128\/AAC.46.8.2676-2678.2002","article-title":"Role of active efflux in association with target gene mutations in fluoroquinolone resistance in clinical isolates of Vibrio cholerae","volume":"46","author":"Baranwal","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0014","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/molbev\/mst197","article-title":"MEGA6: Molecular Evolutionary Genetics Analysis version 6.0","volume":"30","author":"Tamura","year":"2013","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0015","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.meegid.2015.11.029","article-title":"Molecular epidemiology of Vibrio cholerae associated with flood in Brahamputra River Valley, Assam, India","volume":"40","author":"Bhuyan","year":"2016","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0016","doi-asserted-by":"crossref","first-page":"e00624","DOI":"10.1128\/mBio.00624-12","article-title":"Analysis of Vibrio cholerae genome sequences reveals unique rtxA variants in environmental strains and an rtxA-null mutation in recent altered El Tor isolates","volume":"4","author":"Dolores","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0017","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1128\/IAI.00189-16","article-title":"Phenotypic analysis reveals that the 2010 Haiti cholera epidemic is linked to a hypervirulent strain","volume":"84","author":"Satchell","year":"2016","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0018","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(96)01180-4","article-title":"Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae O1 or O139","volume":"348","author":"Khan","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0019","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/S0140-6736(12)60436-X","article-title":"Cholera","volume":"379","author":"Harris","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0020","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.aao2136","article-title":"Integrated view of Vibrio cholerae in the Americas","volume":"358","author":"Domman","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0021","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJMp1013771","article-title":"Antibiotics for both moderate and severe cholera","volume":"364","author":"Nelson","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0022","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.3201\/eid1711.110720","article-title":"Drug-resistance mechanisms in Vibrio cholerae O1 outbreak strain, Haiti, 2010","volume":"17","author":"Sj\u00f6lund-Karlsson","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0023","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jiph.2011.09.007","article-title":"Tetracycline resistant V. cholerae O1 biotype El Tor serotype Ogawa with classical ctxB from a recent cholera outbreak in Orissa, Eastern India","volume":"5","author":"Kumar","year":"2012","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181496","article-title":"Antibiotics resistance in El Tor Vibrio cholerae O1 isolated during cholera outbreaks in Mozambique from 2012 to 2015","volume":"12","author":"Dengo-Baloi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0025","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.3201\/eid2111.150762","article-title":"Sensitivity to polymyxin B in El Tor Vibrio cholerae O1 strain, Kolkata, India","volume":"21","author":"Samanta","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0026","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1128\/IAI.72.6.3577-3583.2004","article-title":"The Vibrio cholera ToxR-regulated porin OmpU confers resistance to antimicrobial peptides","volume":"72","author":"Mathur","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0027","doi-asserted-by":"crossref","first-page":"10220","DOI":"10.1073\/pnas.170219997","article-title":"Altered expression of the ToxR-regulated porins OmpU and OmpT diminishes Vibrio cholerae bile resistance, virulence factor expression, and intestinal colonization","volume":"97","author":"Provenzano","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0028","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1365-2958.2006.05544.x","article-title":"Antimicrobial peptides activate the Vibrio cholerae \u03c3E regulon through an OmpU-dependent signalling pathway","volume":"63","author":"Mathur","year":"2007","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0029","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1128\/JCM.01286-11","article-title":"Characterization of Vibrio cholerae O1 El Tor biotype variant clinical isolates from Bangladesh and Haiti, including a molecular genetic analysis of virulence genes","volume":"49","author":"Son","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0030","doi-asserted-by":"crossref","first-page":"e856","DOI":"10.1016\/S2214-109X(16)30211-X","article-title":"Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case\u2013cohort study","volume":"4","author":"Azman","year":"2016","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0031","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nature13738","article-title":"Members of the human gut microbiota involved in recovery from Vibrio cholerae infection","volume":"515","author":"Hsiao","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2019.11.010_bib0032","series-title":"Ending cholera. A global roadmap to 2030","year":"2017"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919303243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919303243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:33:42Z","timestamp":1760376822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919303243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0924857919303243"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.11.010","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergence of Haitian variant genotype and altered drug susceptibility in Vibrio cholerae O1 El Tor-associated cholera outbreaks in Solapur, India","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105853"}}